Fri, September 9, 2022
Thu, September 8, 2022
Wed, September 7, 2022
Tue, September 6, 2022
Mon, September 5, 2022
Fri, September 2, 2022
Thu, September 1, 2022
Wed, August 31, 2022
Tue, August 30, 2022
Mon, August 29, 2022
Sun, August 28, 2022
Fri, August 26, 2022

Brian Abrahams Maintained (VRTX) at Hold and Held Target at $276 on, Sep 2nd, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. hold-and-held-target-at-276-on-sep-2nd-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Brian Abrahams of RBC Capital, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Hold and Held Target at $276 on, Sep 2nd, 2022.

Brian has made no other calls on VRTX in the last 4 months.



There are 13 other peers that have a rating on VRTX. Out of the 13 peers that are also analyzing VRTX, 5 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Do Kim of "Piper Sandler" Maintained at Hold with Increased Target to $288 on, Wednesday, August 17th, 2022
  • Paul Matteis of "Stifel" Maintained at Hold and Held Target at $263 on, Wednesday, August 10th, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $253 on, Monday, August 8th, 2022
  • Brian Skorney of "Baird" Maintained at Hold and Held Target at $250 on, Friday, August 5th, 2022
  • David Risinger of "SVB Leerink" Initiated at Hold and Held Target at $265 on, Monday, May 23rd, 2022


These are the ratings of the 8 analyists that currently disagree with Brian


  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $307 on, Friday, August 5th, 2022
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $300 on, Friday, August 5th, 2022
  • Olivia Brayer of "Cantor Fitzgerald" Initiated at Buy and Held Target at $365 on, Wednesday, July 13th, 2022
  • Phil Nadeau of "Cowen & Co." Maintained at Buy with Increased Target to $310 on, Monday, June 13th, 2022
  • Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Increased Target to $280 on, Monday, June 13th, 2022
  • Jason McCarthy of "Maxim Group" Upgraded from Hold to Strong Buy and Held Target at $325 on, Wednesday, June 1st, 2022
  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy and Held Target at $278 on, Tuesday, May 24th, 2022
  • Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $305 on, Friday, May 6th, 2022

Publication Contributing Sources